2015
DOI: 10.1038/srep17281
|View full text |Cite
|
Sign up to set email alerts
|

Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central Africa

Abstract: Neonatal invasive disease due to Streptococcus agalactiae is life threatening and preventive strategies suitable for resource limited settings are urgently needed. Protective coverage of vaccine candidates based on capsular epitopes will relate to local epidemiology of S. agalactiae serotypes and successful management of critical infections depends on timely therapy with effective antibiotics. This is the first report on serotype distribution and antimicrobial susceptibility of S. agalactiae in pregnant women … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
29
2

Year Published

2017
2017
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(39 citation statements)
references
References 23 publications
6
29
2
Order By: Relevance
“…However, as seen in both our studies and other studies [2, 4, 14], these GBS vaccines would not protect a large number of women in several African countries.…”
Section: Discussioncontrasting
confidence: 42%
“…However, as seen in both our studies and other studies [2, 4, 14], these GBS vaccines would not protect a large number of women in several African countries.…”
Section: Discussioncontrasting
confidence: 42%
“…The incidence of erythromycin resistance found (21•3%) is similar to previous studies conducted in Ireland (18•6%), Poland (18•4%) and Italy (20%) [5,27,28], but lower than rates in France (34•7%) and Taiwan (46%) [29,30]. Interestingly the rate of clindamycin resistance in the current study indicates that resistance has increased in the Irish population from 15•25% [5] to 20•4% and is higher than reports from other countries, including Poland and Africa [27,31]. As with other countries, a high rate of tetracycline resistance (87•2%) was evident for the isolates reported here [28,29].…”
Section: Discussionsupporting
confidence: 88%
“…Primary studies conducted in the East African countries showed the colonization rates ranged from 3.0% to 28.8% [10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26]; Central Africa,20.0% [27,28]; Western Africa, 2.5% to 34.2% [29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48]; Southern Africa, 1.77% to 48.23% [49][50][51][52][53][54][55][56][57]…”
Section: Introductionmentioning
confidence: 99%
“…GBS isolated from pregnant women in different primary studies conducted in Africa showed resistance to penicillin, ampicillin, erythromycin, clindamycin, vancomycin, ciprofloxacin, chloramphenicol, and tetracycline [10,11,15,31,36,65]. Unlike to Western countries, few data are available about GBS serotypes in different parts of the Africa since the 1989 in Ethiopia to 2018 in Morocco [22,28,30,31,33,39,49,54,66]. A review from the USA on GBS serotypes showed lower proportions of women with serotypes Ia, Ib, or III with the mean prevalence estimate of 55.0%, and in Europe, 58.3% [67].…”
Section: Introductionmentioning
confidence: 99%